English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

This research aimed to describe trends in the use of telemedicine and take-home medication, as well as restrictions in service provision among Medication-Assisted Treatment and inpatient services. We surveyed trendsduring the first 18 months of the COVID-19 pandemic (March 2020-August 2021) in Israel. We sent a mail-based survey to 13 Medication-Assisted Treatment and 11 inpatient centers under state supervision. We also collected data on COVID-19 cases and quarantines from routine reports. While quarantines in Medication-Assisted Treatment centers increased in each successive COVID-19 wave, those in inpatient centers declined by 63% from December to April 2021. Restriction of services, use of telemedicine, and take-home schemes decreased between 2020 and 2021. Inpatient services were significantly disrupted during 2020, and ten centers (91%) reported limiting patient admissions. Although most centers in 2020 adopted telemedicine and take-home schemes, less than half of centers continued employing them in 2021, suggesting provider, and patient preference for pre-pandemic models of care.

Transformation of substance use disorder treatment services during COVID-19 - A lasting change?